Abstract -Development of an industrial process for producing 7432-S, a new oral cephem antibiotic, is outlined. The required components, 2-(2-benzyloxycarbonylamino-4-thiazolyl )-4-(3-methylbut-2-enyloxycarbonyl )but-2-enoic acid (2b) and diphenylmethyl 7-amino-3-cephem-4-carboxylate (3b) (or its precursor 3'), were prepared starting from methyl 2-(2-amino-4-thiazolyl)acetate T12) and penicillin G, respectively. Condensation of the two components followed by deprotection (after reduction or elimination) and epimerization-crystallization gave 7432-S in 36-42% overall yields from penicillin G. Special efforts have been made to utilize inexpensive and non-hazardous materials and to maximize one-pot procedures.
INTRODUCTION
3'-Norcephalosporins (1: R1 = H or a non-carbon substituent) are an important class of heteroatom antibiotics which have been widely used in the treatment of a variety of infections. Since the 3'-nor nuclei are not naturally occurring, they should be derived from penicillins or cephalosporins, comercially available fermentation products (ref. 1) . Recently we at Shionogi have been developing 7432-S, a new oral 3'-norcephalosporin exhibiting a potent activity against most gram-negative and some gram-positive bacteria, with a very excellent oral bioavailability (ref.
2), and have needed to explore an industrial synthetic route to this antibiotic (Fig. 1 ). This paper outlines our efforts to develop an industrially feasible, economical process for producing 7432-S, starting from penicillin G, the least expensive -lactam. 7432-S can be produced by condensing a 7-side chain acid 2 with a 7-aminocephem nucleus 3 or its precursor 3', followed by elimination or reduction when 3' is used, deprotection, epimerization and finally crystallization (Fig. 2) . Thus, the keys for successful largescale production of 7432-S would be economical preparation of these components 2 and 3 or 3' as well as efficient epimerization-crystallization to yield only 7432-S [(Z)-isomer] from a mixture with its (E)-isomer, with taking into account the following crucial factors for industrialization: The synthetic route applied to earlier preparation of acid 2a consists of facile conversion of diketene into diphenylmethyl 2-(2-amino-4-thiazolyl)acetate (6), amine protection followed by formylation to give enol 7, Wittig reaction affording diester Sa and partial deprotection of the diphenylmethyl ester to yield the objective acid 2a. This route has the following problems (rectangles in Fig. 3 ) that make the scale-up difficult: 1. The formylation using sodium hydride was exothermic and difficult to control on large scales. 2. In the Wittig reaction, the phosphorane reagent was considerably expensive and impractical chromatographic separation of triphenylphosphine oxide was necessary. Thus, extensive studies were initiated to search for more practical synthesis of the 7-side chain acid 2. Soon an attractive route (Fig. 4 ) has been found which consists of conversion of the acetonedicarboxylate-magnesium complex 9 into aminothiazolyl enol 10, borohydride reduction to alcohol U and the three-step transformation into diester 8b that can be derived to acid 2 as discussed later. This route has been given up without making any attempts to improve the low yield (59%) of enol 10, when dimethyl 1,3-acetonedicarboxylate turned out to be considerably expensive.
After many unsuccessful attempts, we could finally reach to an industrially feasible fourstep process for producing acid 2 starting from methyl 2-(2-amino-4-thiazolyl)acetate (12), an inexpensive, abundant material (Fig. 5) . Acylation of 12 with benzyl chloroformate (Z-C1) proceeded quite satisfactorily under the Schotten-Baumann conditions to give protected ester 13b which was condensed with methyl -methoxyacry1ate to afford diester 8b. Unexpectedly, similar Michael condensation of ester 13c with 3-chloro-or mesyloxyacrylate did not yield diester 8c in our earlier attempts to delay the use of -methoxyacrylate, a seemingly less-reactive Michael acceptor. Diester 8b obtained as a toluene extract was easily hydrolyzed with aqueous alkali in a two-phase system to give diacid 14 which could be partially esterified to half ester 2 with an alcohol in the presence of an acid catalyst. In this tricky procedure, steric hindrance and relative carboxyl basicity seem to be important factors for selective monoesterification and only primary alcohols or some (less-hindered) secondary alcohols catalyzed by a strong acid can smoothly attack the primary carboxylic acid in a regiospecific manner leading to half ester 2. Thus, tert-butyl alcohol and diphenylmethanol, favorable protecting alcohols, can not be used and protecting primary alcohols other than problematic benzyl alcohol have been sought. Para-methoxybenzyl alcohol and 3-methyl-2-buten-1-ol (prenyl alcohol) were found satisfactory, of which the latter was selected from its lower price. Thus, the required 7-side chain component 2b has been produced in 71% overall yield on pilot-plant scales. Incidentally, an attempt failed to obtain the half ester2a by direct Michael condensation of -alkoxyacrylate with a dianion of thiazolylacetic acid 15.
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MeOCH =CHCO2Me Z-AMT-C-CO2Me Two routes have been still competing for transforming this intermediate 24b into the desired 7-amino nuclei 3 and 3' (Fig. 8) . One route consists of smooth mesylation of 24b to enol mesylate 26 and the side-chain cleavage by the well-established two-step, onepot procedure giving 3-mesyloxy-7t3-aminocephem 3'b, which can be used as the acylation substrate with or without further zinc-acid reduction to amine 3b. Another route involves borohydride reduction of 3-hydroxycephem 24b at low temperature affording 3-hydroxycepham 27 and mesylation followed by the side-chain cleavage to give 7-aminocepham 3'c, which can be used as the acylation substrate or eliminated with base to amine3b. The low temperature (below -60°C) is crucial for successful hydride reduction to 3-hydroxycepham 27 (ref. 6), because its yield was greatly reduced with formation of diphenylmethanol and by-product 27' when the reduction temperature was raised to 0°C as exemplified in the literature (ief. 7). Interestingly, the hydride attack occurred at the seemingly more In our improved industrial process, penicillin G diphenylmethyl ester obtained as an extract was oxidized with hydrogen peroxide in the presence of formic acid and polyphosphoric acid (probably assisting the formation of performic acid, ref. 5) to give S-oxide ester 17b in excellent yield, which was converted into enol 1gb by ozonolysis of thiazoline 18b with substituting trimethyl phosphite for low-boiling dimethyl sulfide. When methanesulfonyl chloride (MsCl) was replaced by p-toluenesulfonyl chloride (TsCl) in our one-pot process, the C-sulfonyl by-product like 21 was not formed and 3-hydroxycephem intermediate 24b obtained in 63% overall yield on pilot-plant scales, where only three crystallization-isolation procedures were necessary (Fig. 7 ). . With regard to comparison of the two synthetic routes, the former route seems somewhat advantageous at present, but the final selection will be made after comparing these routes including the choice of the acylation substrate on pilot-plant scales.
Acylation of the 713-amino nuclei 3b, 3'b, and 3'c with the side chain acid 2b could be effected by the usual methods employing mesyl chloride, phosphorus oxychloride, thionyl chloride etc as the condensing agent in the presence of a base such as triethylamine or pyridine. Diester4b containing the (E)-isomer predominantly was obtained in excellent yield, after zinc-acid reduction or base elimination when precursor 3'b or 3c was used. The three protecting groups in diester 4b could be smoothly deblocked at once by our practical, aluminum trichloride-anisole procedure (ref. 10) (Fig. 9) . However, isolation of 7432-S from the reaction mixture was not straightforward, because amino acids, 7432-S and its (E)-isomer, could not be extracted with an appropriate solvent or precipitated out from the acid-treatment mixture containing a large amount of aluminum trichloride. PRODUCTION OF 7432-S First, a procedure utilizing a big column of HP-2O, a high porous polymer supplied by Mitsubishi Chemical Industries, has been developed to adsorb the amino acid product which could be eluted with dilute alkali, after washing out aluminum trichloride with water, to yield disodium salt 29. The dilute eluates containing 29 were concentrated by using a reverse osmosis membrane such as NTR-7250-S4® (Nitto Electric Industrial Co., Ltd.) and then adjusted to pH about 3 to precipitate 7432-S as fine crystals. Fortunately, the unwanted (E)-isomer formed as a major product is considerably soluble in the aqueous acid solution where rapid equilibration with the desired (Z)-isomer occurs to finally precipitate out only a less-soluble (Z)-isomer, 7432-S. Later, this procedureneeding a large equipment was taken over by a precipitation procedure using acetylacetone. In the improved procedure, the acid layer containing aluminum trichloride and the amino acid product was mixed with acetylacetone and then adjusted to pH about 6 to form the aluminum hydroxide-acetylacetone complex that, unlike aluminum hydroxide itself, could be easily filtered off. The filtrate containing disodium salt 29 was adjusted to pH about 3 to yield 7432-S. The overall yields are 36-42% from penicillin G.
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CONCLUSION
In production of a new oral cephem antibiotic, 7432-S, the required 7-side chain component was prepared in 71% overall yield by a four-step process starting from ester 12 (Fig. 5 ) and the 7-amino nucleus 3b (or its precursor) in 53% overall yield by a several-step process starting from penicillin G (Figs. 7 & 8 ). 7432-S was then obtained in '75% yield by condensation of the two components, (reduction or elimination), deprotection, and epimerization-crystallization (Fig. 9) . The successful development of this industrial process, utilizing inexpensive and non-hazardous heteroatom materials without any chromatographic separation, not only facilitates industrial production of our new useful oral antibiotic, 7432-S, but also would contribute to production of other 3'-norcephalosporin antibiotics which could be derived from a 3-hydroxycephem intermediate such as 24b or a 7-aminocephem nucleus such as 3b.
